Experts in gastroenterology provide insight on various case studies and the optimal treatment approaches for the management of HCC.
EP. 1: Updates to Adjuvant and Neoadjuvant Therapy in Early HCC
Stephen L. Chan, MD, reviews the case of a 72-year-old woman with mild alcoholic cirrhosis and provides insight on the potential role of adjuvant and neoadjuvant therapy for the treatment of HCC.
EP. 2: Role of TACE and TARE in the Treatment of HCC
Andrea Casadei Gardini, MD, and Stephen L. Chan, MD, examine the use of TACE and TARE-Y90 for the treatment of HCC.
EP. 3: Is There a Role for Systemic Therapy for Patients With Intermediate HCC?
Gastroenterology experts discuss whether there a is a role for systemic therapy for the management of intermediate HCC.
EP. 4: Updates to First-line Treatment Options for Advanced HCC
Andrea Casadei Gardini, MD, presents the case of a 63-year-old man diagnosed with advanced HCC, and the panel reviews available first-line treatment options for patients with advanced HCC.
EP. 5: Optimizing the Selection of Frontline TKIs for Advanced HCC
Experts in gastroenterology share their approaches to first-line single-agent and combination TKI therapies for the treatment of advanced HCC.
EP. 7: Treatment Options for Advanced HCC With Underlying NASH
A panel of experts in gastroenterology review the case of a 65-year-old man with advanced HCC associated with NASH and comment on treatment with TKIs and immunotherapy.
EP. 8: Management of Advanced HCC Associated With NASH
Stephen L. Chan, MD, leads the discussion on the prevalence and management of advanced HCC in patients with NASH.